Clinical Trial Update: A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia [Phase 4]

View source ↗

Summary

Phase 4 safety trial assessing epoetin alfa in cancer patients with chemotherapy-related anemia. The results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Neoplasms | Phase 4 | Status: COMPLETED | Results posted: 2011-07-15